CellPly's Series A Round

CellPly raised a round of funding on March 20, 2014.

Cellply is a biotechnology company committed to the development of solutions for personalized cancer therapy based on diagnostic platforms that define cell response to drug treatments. Its micro-techn…

Articles about CellPly's Series A Round: